← All stocks

ADMA BIOLOGICS, INC.

ADMA Balanced
CIK 0001368514 #1977 in the set updated 18 Sep 2026
Bought (120 mo)
$50.14M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$77.56M
$0.00 on a plan · $25.10M straight out of an exercise
Sold at will
$52.46M
28 of 64 sales
Net
−$27.42M
−$2.32M against sales at will

By person

19 insiders · 131 transactions
32.8×

Adam S. Grossman holds 32.8 times base salary in stock. $30.35M of shares against $925.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam S. Grossman last reported holding, valued at $7.91, the price Common Stock was last bought or sold at on the open market here, on 27 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PERCEPTIVE ADVISORS LLC entity
10% owner
$33.02M (3)
$4.25M (9)
+$28.78M
28,065,353
12.53%
$222.00M
+25.7%
Biotest Divestiture Trust entity
10% owner
$21.80M (2)
−$21.80M
14,405,114
6.43%
$113.94M
−50.0%
Grossman Adam S
President and CEO
$2.28M (16)
$20.91M (31) scheduled
−$18.63M
3,837,160
1.71%
$30.35M
+375.7%
ELMS STEVE
Director
$217.42K (2)
$17.97M (8)
−$17.76M
2,143,750
0.9571%
$16.96M
−40.6%
Biotest AG
10% owner
$12.50M (1)
(1)
+$12.50M
10,109,534
4.51%
$79.97M
−21.6%
Fong Bryant
Director
$5.54M (1)
−$5.54M
83,941
0.0375%
$663.97K
−94.1%
LENZ BRIAN
EVP, CFO
$144.73K (7)
$1.77M (2) scheduled
−$1.62M
703,002
0.3139%
$5.56M
Grossman Jerrold B
Director
$1.35M (16)
$2.58M (2) scheduled
−$1.23M
520,459
0.2324%
$4.12M
+3,626%
KWON YOUNG
Director
$197.50K (2)
$1.10M (1)
−$898.10K
263,020
0.1174%
$2.08M
+116.0%
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
$565.85K (2) scheduled
−$565.85K
443,061
0.1978%
$3.50M
+68.2%
Guiheen Lawrence P.
Director
$265.60K (3)
$768.02K (4)
−$502.42K
136,520
0.0610%
$1.08M
Tade Brad L.
CFO and Treasurer
$317.25K (1)
−$317.25K
232,940
0.1040%
$1.84M
+64.0%
Mond James
EVP, CSO and CMO
$83.45K (6)
+$83.45K
137,535
0.0614%
$1.09M
+3,958%
RICHMAN ERIC I
Director
$78.75K (2)
+$78.75K
44,030
0.0197%
$348.28K
+1,158%
DEMSKI MARTHA J
Director
$10.80K (2)
+$10.80K
60,801
0.0271%
$480.94K
+1,348%
Kohler Terry
CFO and Treasurer
143,149
0.0639%
$1.13M
+146.7%
FINGER ALISON CECILY
Director
45,619
0.0204%
$360.85K
Salas Eduardo Rene
Director
21,579
0.0096%
$170.69K
GOLDSTEIN DOV A MD
Director
7,500
0.0033%
$59.33K
Insider
Date
Role
Action
Shares
Price
Amount
Guiheen Lawrence P.
13 Mar 2026
Director
Exercised, kept
30,000
$3.66
$109.80K
Kestenberg-Messina Kaitlin M.
30 Jul 2025
COO and SVP, Compliance
Exercised, kept
2,500
$8.98
$22.45K
Kestenberg-Messina Kaitlin M.
30 Jan 2025
COO and SVP, Compliance
Exercised, kept
5,000
$10.80
$54.00K
ELMS STEVE
27 Nov 2024
Director
Exercised, kept indirect
9,000
$10.80
$97.20K
RICHMAN ERIC I
13 Jul 2017
Director
Exercised, kept
2,800
$2.68
$7.50K
Grossman Jerrold B
13 Jul 2017
Director
Exercised, kept
48,185
$2.68
$129.14K
Grossman Adam S
13 Jul 2017
President and CEO
Exercised, kept
42,021
$2.68
$112.62K

What was left out

Form 4 filings counted 237
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 36
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 15,418,958
Sales filed before the plan box existed 12
History held since 16 Feb 2017